Summary
Greg Scott is a founder and life sciences executive with 15+ years of experience scaling commercial, program, and portfolio operations across CDMO, biologics, and advanced therapy platforms. He has built and led global teams of 40–70 people, implemented enterprise S&OP and governance frameworks, and aligned commercial strategy to multi‑billion dollar growth ambitions. Greg combines engineering rigor (B.S. Mechanical Engineering) and an MBA in strategy to bridge technical, operational, and commercial priorities, improving EBITDA and client retention at scale. He’s particularly experienced guiding organizations through inflection points—commercialization readiness, strategic partnerships, and platform expansion—often serving as fractional executive or board advisor. A pragmatic operator who has driven program delivery across multi‑site GMP networks, he brings a hands‑on mix of portfolio governance, vendor management, and negotiation skills. Based in Cambridge, MA, Greg focuses on enabling technologies shaping the future of biologics and advanced therapies.
15 years of coding experience
18 years of employment as a software developer
B.S., Mechanical Engineering, B.S., Mechanical Engineering at Union College
MBA, Strategy & Business Analysis (SBA), and Entrepreneurship, MBA, Strategy & Business Analysis (SBA), and Entrepreneurship at Questrom School of Business, Boston University
Spanish